Carisoprodol
27 NDCs across 11 manufacturers|24 Generic,3 Brand
Carisoprodol is used to treat muscle cramp, muscle rigidity, muscle spasticity, myositis, pain and spasm, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $6 million on Carisoprodol across 348,000 claims for 63,000 beneficiaries.
Carisoprodol is available as 27 NDCs from 11 manufacturers (24 generic, 3 brand), with NADAC prices from $0.05 to $11.30 per EA — the most expensive product costs about 238× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
27
24G / 3B
Manufacturers
11
competing in market
Price Spread
$0.05 – $11.30
per EA
7d Activity
avg +8.2% WoW · of 27 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Muscle Relaxant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing CARISOPRODOL(1 pricing outlier)
Frequently Asked Questions
What is Carisoprodol used to treat?
Carisoprodol is used to treat muscle cramp, muscle rigidity, muscle spasticity, myositis, pain and spasm, per the National Library of Medicine's MED-RT classification.
When did Carisoprodol become available as a generic?
FDA approved the first generic Carisoprodol (ANDA) on Jan 1, 1982. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Carisoprodol?
In 2024, Medicare Part D spent $6 million on Carisoprodol across 348,000 claims for 63,000 beneficiaries.
How many Carisoprodol products are on the market?
The Carisoprodol drug market contains 27 NDCs from 11 manufacturers — 24 generic and 3 brand products.
What is the price range for Carisoprodol?
NADAC reference prices for Carisoprodol range from $0.0475 to $11.2975 per EA — the most expensive product costs about 238× the cheapest.
Is generic Carisoprodol cheaper than brand?
The average generic NADAC for Carisoprodol is $0.1549 per EA, versus $7.2190 for brand-labeled products — brand versions average about 47× the generic price.
Which manufacturers make Carisoprodol?
11 manufacturers list Carisoprodol in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (4), Rising Pharma Holdings Inc. (4), Viatris Specialty LLC (3), Westminster Pharmaceuticals LLC (3), Oxford Pharmaceuticals, LLC (3).
How has the price of Carisoprodol changed recently?
Over the past 7 days, 17 Carisoprodol NDCs rose and 1 fell, with a market-wide average change of +8.2%.